Geneos Wealth Management’s PIMCO 15+ Year US TIPS Index Exchange-Traded Fund LTPZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51K Buy
30
+1
+3% +$51 ﹤0.01% 2368
2026
Q1
$1.48K Hold
29
﹤0.01% 2354
2025
Q4
$1.5K Sell
29
-20
-41% -$1.06K ﹤0.01% 2361
2025
Q3
$2.62K Buy
+49
New +$2.56K ﹤0.01% 2279
2024
Q2
Sell
-15
Closed -$833 2136
2024
Q1
$833 Buy
+15
New +$830 ﹤0.01% 2062
2020
Q4
Sell
-100
Closed -$8K 2950
2020
Q3
$8K Hold
100
﹤0.01% 2030
2020
Q2
$8K Hold
100
﹤0.01% 1985
2020
Q1
$8K Sell
100
-150
-60% -$11.4K ﹤0.01% 1893
2019
Q4
$18K Buy
250
+150
+150% +$10.9K ﹤0.01% 1732
2019
Q3
$7K Buy
+100
New +$7.24K ﹤0.01% 2007

Other funds holding LTPZ

Geneos Wealth Management's LTPZ Position: Q2 2026 in Review

Geneos Wealth Management increased its PIMCO 15+ Year US TIPS Index Exchange-Traded Fund (LTPZ) stake by 3.4% in Q2 2026, buying an estimated $51 and bringing the position to 30 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

Geneos Wealth Management first reported a position in LTPZ in Q3 2019 and has held it in 10 quarters since. The position peaked at $18K in Q4 2019. 97 funds tracked by Wall St. Rank hold LTPZ as of Q2 2026.

  • Geneos Wealth Management held 30 shares of PIMCO 15+ Year US TIPS Index Exchange-Traded Fund worth $1.51K as of Q2 2026.
  • Geneos Wealth Management bought 1 PIMCO 15+ Year US TIPS Index Exchange-Traded Fund share in Q2 2026, an estimated $51.
  • PIMCO 15+ Year US TIPS Index Exchange-Traded Fund made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2368 holding.
  • Geneos Wealth Management first reported a position in PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q3 2019 and has held it in 10 quarters since.
  • Geneos Wealth Management's PIMCO 15+ Year US TIPS Index Exchange-Traded Fund position peaked at $18K in Q4 2019.
  • 97 funds tracked by Wall St. Rank held PIMCO 15+ Year US TIPS Index Exchange-Traded Fund as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.